Deleobuvir

DB14850InvestigationalSmall molecule

Deleobuvir is under investigation in clinical trial NCT01983566 (Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese...

Mechanism: Pharmacologically active on RNA-directed RNA polymerase
Curator reviewed
Formula / weight: C₃₄H₃₃BrN₆O₃ · 653.581 g/mol (avg)
Code names: BI 207127

Resolves to

Compound

UNII58BU988K90CAS863884-77-9ChEMBLCHEMBL2403318

Clinical / RWD

PharmGKBPA166128130

Structure

InChIKeyBMAIGAHXAJEULY-UKTHLTGXSA-NSMILESCN1C2=C(C=CC(\C=C\C(O)=O)=C2)N=C1C1(CCC1)NC(=O)C1=CC2=C(C=C1)C(C1CCCC1)=C(N2C)C1=NC=C(Br)C=N1

Targets

O39930NS5bP26664Genome polyprotein

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Deleobuvir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account